Clinical trial
A Retrospective, Observational Cohort Study Evaluating the Effectiveness and Cardiovascular Safety of Abaloparatide in Postmenopausal Women New to Anabolic Therapies
NCT04974723 is registered in ClinicalTrials.gov with Radius Health, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective, Observational Cohort Study Evaluating the Effectiveness and Cardiovascular Safety of Abaloparatide in Postmenopausal Women New to Anabolic Therapies
- Lead sponsor
- Radius Health, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2021
- Completion date
- September 30, 2021
- Enrollment
- 22,054 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.